Columbus, OH 的 結腸癌 臨床試驗
11 項針對 結腸癌 的研究正在 Columbus（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
招募中1 期
- ALX Center 10, Columbus
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
- Ohio Health, Columbus
- Zangmeister Center, Columbus
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
招募中
- Ohio State University Comprehensive Cancer Center, Columbus
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
招募中2/3 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- 還有 6 項
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
招募中1 期
- Xencor Investigative Site, Columbus
Strategies for Optimizing a Mailed FIT Program in Appalachia
招募中
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- The Ohio State University Wexner Medical Center, Columbus
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
招募中歡迎健康志工
- Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
招募中1/2 期
- The Ohio State University, Columbus
其他城市的 結腸癌 試驗
- Boston, MA22 項研究
- New York City, NY22 項研究
- Houston, TX20 項研究
- Los Angeles, CA16 項研究
- Nashville, TN16 項研究
- St. Louis, MO15 項研究
- Arlington, VA15 項研究
- Chicago, IL14 項研究
- San Antonio, TX14 項研究
- Baldwin Park, CA14 項研究
- Baltimore, MD13 項研究
- Tampa, FL13 項研究
Columbus 的其他研究
- 非小細胞肺癌57 項研究
- 乳癌40 項研究
- 卵巢癌39 項研究
- 癌症（所有類型）38 項研究
- 肺癌37 項研究
- 急性髓系白血病35 項研究
- 慢性淋巴性白血病28 項研究
- 轉移性癌症27 項研究
- 子宮內膜癌25 項研究
- 前列腺癌24 項研究
- 多發性骨髓瘤24 項研究
- 大腸直腸癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。